Courtesy of Benzinga.
HC Wainwright initiated coverage on Flex Pharma, Inc. (NASDAQ: FLKS) with a Buy rating.
The target price for Flex Pharma is set to $40.
Flex Pharma shares closed at $19.46 yesterday.
Latest Ratings for FLKS
Date | Firm | Action | From | To |
---|---|---|---|---|
Apr 2015 | HC Wainwright | Initiates Coverage on | Buy | |
Mar 2015 | Cantor Fitzgerald | Maintains | Buy | |
Feb 2015 | Roth Capital | Initiates Coverage on | Buy |
View More Analyst Ratings for FLKS
View the Latest Analyst Ratings
Posted-In: HC WainwrightInitiation Analyst Ratings